Anifrolumab for Hidradenitis Suppurativa

NCT06374212 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Hidradenitis Suppurativa
Acne Inversa
Hidradenitis

Interventions

DRUG: Anifrolumab

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]